JP2020040996A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020040996A5 JP2020040996A5 JP2019229254A JP2019229254A JP2020040996A5 JP 2020040996 A5 JP2020040996 A5 JP 2020040996A5 JP 2019229254 A JP2019229254 A JP 2019229254A JP 2019229254 A JP2019229254 A JP 2019229254A JP 2020040996 A5 JP2020040996 A5 JP 2020040996A5
- Authority
- JP
- Japan
- Prior art keywords
- supernatant
- maintaining
- medium
- undifferentiated state
- cultured
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 26
- 239000006228 supernatant Substances 0.000 claims 24
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 210000001339 epidermal cell Anatomy 0.000 claims 6
- 210000002950 fibroblast Anatomy 0.000 claims 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims 2
- 239000012190 activator Substances 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 230000004663 cell proliferation Effects 0.000 claims 2
- 230000003833 cell viability Effects 0.000 claims 2
- 230000037319 collagen production Effects 0.000 claims 2
- 230000001120 cytoprotective effect Effects 0.000 claims 2
- 230000002500 effect on skin Effects 0.000 claims 2
- 230000003779 hair growth Effects 0.000 claims 2
- 229920002674 hyaluronan Polymers 0.000 claims 2
- 229960003160 hyaluronic acid Drugs 0.000 claims 2
- 238000007665 sagging Methods 0.000 claims 2
- 230000006711 vascular endothelial growth factor production Effects 0.000 claims 2
- 230000035899 viability Effects 0.000 claims 2
- 239000003357 wound healing promoting agent Substances 0.000 claims 2
- 230000037303 wrinkles Effects 0.000 claims 2
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023009392A JP2023038330A (ja) | 2017-05-02 | 2023-01-25 | 医薬品組成物及び化粧品組成物 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762500117P | 2017-05-02 | 2017-05-02 | |
| US62/500,117 | 2017-05-02 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019515707A Division JP6647545B2 (ja) | 2017-05-02 | 2018-04-25 | 医薬品組成物及び化粧品組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023009392A Division JP2023038330A (ja) | 2017-05-02 | 2023-01-25 | 医薬品組成物及び化粧品組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020040996A JP2020040996A (ja) | 2020-03-19 |
| JP2020040996A5 true JP2020040996A5 (enExample) | 2021-06-10 |
| JP7222471B2 JP7222471B2 (ja) | 2023-02-15 |
Family
ID=64017009
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019515707A Active JP6647545B2 (ja) | 2017-05-02 | 2018-04-25 | 医薬品組成物及び化粧品組成物 |
| JP2019229254A Active JP7222471B2 (ja) | 2017-05-02 | 2019-12-19 | 医薬品組成物及び化粧品組成物 |
| JP2023009392A Pending JP2023038330A (ja) | 2017-05-02 | 2023-01-25 | 医薬品組成物及び化粧品組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019515707A Active JP6647545B2 (ja) | 2017-05-02 | 2018-04-25 | 医薬品組成物及び化粧品組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023009392A Pending JP2023038330A (ja) | 2017-05-02 | 2023-01-25 | 医薬品組成物及び化粧品組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20200147146A1 (enExample) |
| EP (1) | EP3607957A4 (enExample) |
| JP (3) | JP6647545B2 (enExample) |
| CN (2) | CN110621323B (enExample) |
| WO (1) | WO2018203499A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110621323B (zh) * | 2017-05-02 | 2022-10-14 | 田边刚士 | 医药品组合物及化妆品组合物 |
| JPWO2020218579A1 (enExample) * | 2019-04-26 | 2020-10-29 | ||
| WO2021144843A1 (ja) * | 2020-01-14 | 2021-07-22 | 株式会社ハーバーリンクスジャパン | バイオ化粧品組成物 |
| CN114504636B (zh) * | 2022-01-27 | 2023-09-26 | 华南理工大学 | 一种杏仁油烫伤膏及其制备方法与应用 |
| WO2023149408A1 (ja) * | 2022-02-02 | 2023-08-10 | 株式会社ユーグレナ | 化粧料組成物、表皮角化細胞増殖用化粧料組成物、表皮角化細胞増殖剤、抗酸化剤、毛乳頭細胞増殖用化粧料組成物、毛乳頭細胞増殖剤、育毛剤、ロリクリン遺伝子発現促進剤、ヘムオキシゲナーゼ－１遺伝子発現促進剤及びコーニファイドエンベロープ形成促進剤 |
| JPWO2023176187A1 (enExample) * | 2022-03-15 | 2023-09-21 | ||
| WO2024176985A1 (ja) * | 2023-02-20 | 2024-08-29 | アイ ピース， インコーポレイテッド | 組成物 |
| CN116725927B (zh) * | 2023-08-09 | 2023-11-17 | 美出莱(杭州)化妆品有限责任公司 | 一种含牡丹活性成分的空间结构组合物及其制备方法与应用 |
| CN117180149B (zh) * | 2023-08-16 | 2024-04-30 | 宝萃生物科技有限公司 | 一种舒缓组合物及其制备方法与应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005062791A2 (en) * | 2003-12-20 | 2005-07-14 | Jeffrey Sebastian | Utilization of stem cell and fibroblast combined products and nutrients in topical compositions |
| EP1730261A4 (en) * | 2004-03-10 | 2007-11-28 | Univ California | COMPOSITIONS AND METHODS FOR GROWING EMBRYONIC STEM CELLS |
| KR101420740B1 (ko) | 2005-12-13 | 2014-07-17 | 교또 다이가꾸 | 핵초기화 인자 |
| WO2007097993A2 (en) * | 2006-02-16 | 2007-08-30 | The Burnham Institute Of Medical Research | Media conditioned by human embryonic stem cells or other progenitor cells and uses therefor |
| US20110117645A1 (en) * | 2008-03-31 | 2011-05-19 | Oriental Yeast Co., Ltd. | Method for proliferation of pluripotent stem cells |
| CN101538553A (zh) * | 2009-02-06 | 2009-09-23 | 叶尚勉 | 从人类早期流产的胎儿组织分离纯化和培养增殖全能干细胞的方法 |
| CA2777552C (en) * | 2009-10-19 | 2019-05-21 | Cellular Dynamics International, Inc. | Cardiomyocyte production |
| EP2499236B1 (en) * | 2009-11-12 | 2020-01-01 | Technion Research & Development Foundation Ltd. | Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state |
| EP2554175B1 (en) * | 2010-03-26 | 2018-02-28 | Tokushima University | Composition for treatment of damaged part |
| US8765470B2 (en) * | 2010-08-04 | 2014-07-01 | Cellular Dynamics International, Inc. | Reprogramming immortalized B-cells to induced pluripotent stem cells |
| CN106893692B (zh) * | 2010-12-22 | 2021-11-26 | 菲特治疗公司 | 用于单细胞分选与增强ipsc重新编程的细胞培养平台 |
| JP2012143229A (ja) * | 2010-12-24 | 2012-08-02 | Chiba Univ | 多能性幹細胞培養用組成物およびその用途 |
| KR101293637B1 (ko) * | 2011-01-14 | 2013-08-13 | 서울대학교병원 | 줄기세포의 부유배양용 조성물 |
| TWI649095B (zh) * | 2012-02-10 | 2019-02-01 | 捷百克股份有限公司 | 以非人類幹細胞之培養上清液為起始材料之化妝品或皮膚再生促進劑、及蛋白質之離子導入法 |
| EP3409761B1 (en) * | 2012-07-24 | 2025-09-03 | Nissan Chemical Corporation | Culture medium composition, and method for culturing cell or tissue using said composition |
| CN104919048B (zh) * | 2012-10-01 | 2018-10-26 | 台北荣民总医院 | 制备诱导多能干细胞的方法及其应用 |
| SG11201505965TA (en) * | 2013-01-31 | 2015-09-29 | Ajinomoto Kk | Culture method for stable undifferentiated proliferation of pluripotent stem cells |
| KR101655383B1 (ko) * | 2013-07-27 | 2016-09-08 | 고려대학교 산학협력단 | 소분자 화합물을 포함하는 만능성 줄기세포의 염색체 안정성 유지용 조성물 |
| WO2015098111A1 (ja) * | 2013-12-26 | 2015-07-02 | 国立大学法人広島大学 | ｉＰＳ細胞の樹立方法および幹細胞の長期維持方法 |
| JP6512662B2 (ja) * | 2014-01-23 | 2019-05-15 | 日産化学株式会社 | 未分化性維持培養材料 |
| CN103976929A (zh) * | 2014-05-07 | 2014-08-13 | 王浩 | 一种具有iPS活细胞液和生物多肽美白的化妆品 |
| JP6113133B2 (ja) * | 2014-11-06 | 2017-04-12 | 日本メナード化粧品株式会社 | 幹細胞の未分化状態維持剤及び増殖促進剤 |
| JP2016128396A (ja) * | 2015-01-09 | 2016-07-14 | 上田 実 | ｉＰＳ細胞培養上清を含む医薬組成物およびその製造方法、化粧品およびその製造方法、抗加齢組成物、疾患発症抑制方法、疾患治療方法、組織異常治療方法ならびに美容方法 |
| WO2016164915A1 (en) | 2015-04-09 | 2016-10-13 | Neostem Oncology, Llc | Stem cell compositions for cosmetic and dermatologic use |
| CN106244652B (zh) * | 2016-08-17 | 2019-11-08 | 广州宏柯源生物科技有限公司 | 一种人间充质干细胞培养上清液冻干粉的制备方法及制得的冻干粉 |
| CN110621323B (zh) * | 2017-05-02 | 2022-10-14 | 田边刚士 | 医药品组合物及化妆品组合物 |
-
2018
- 2018-04-25 CN CN201880029436.XA patent/CN110621323B/zh active Active
- 2018-04-25 EP EP18794056.4A patent/EP3607957A4/en active Pending
- 2018-04-25 CN CN202210686304.2A patent/CN114939097A/zh not_active Withdrawn
- 2018-04-25 US US16/610,471 patent/US20200147146A1/en active Pending
- 2018-04-25 JP JP2019515707A patent/JP6647545B2/ja active Active
- 2018-04-25 WO PCT/JP2018/016738 patent/WO2018203499A1/ja not_active Ceased
-
2019
- 2019-12-19 JP JP2019229254A patent/JP7222471B2/ja active Active
-
2023
- 2023-01-25 JP JP2023009392A patent/JP2023038330A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020040996A5 (enExample) | ||
| Wanjare et al. | Perivascular cells in blood vessel regeneration | |
| Zeisberg et al. | Biomarkers for epithelial-mesenchymal transitions | |
| Peters | Endothelial progenitor cells for the vascularization of engineered tissues | |
| Song et al. | The repairing of full-thickness skin deficiency and its biological mechanism using decellularized human amniotic membrane as the wound dressing | |
| Fuest et al. | Advances in corneal cell therapy | |
| Ehrlich et al. | Collagen organization critical role in wound contraction | |
| Leonardi et al. | Mesenchymal stem cells combined with an artificial dermal substitute improve repair in full-thickness skin wounds | |
| Koobatian et al. | Differential effects of culture senescence and mechanical stimulation on the proliferation and leiomyogenic differentiation of MSC from different sources: implications for engineering vascular grafts | |
| CN110621323B (zh) | 医药品组合物及化妆品组合物 | |
| Kober et al. | Generation of a fibrin based three‐layered skin substitute | |
| Simpson et al. | Hyaluronan is crucial for stem cell differentiation into smooth muscle lineage | |
| JP2013524837A5 (enExample) | ||
| RU2015156492A (ru) | Способ получения ренальных клеток-предшественников содержащее их лекарственное средство | |
| JP2010193721A5 (enExample) | ||
| Rajasingh et al. | Generation of functional cardiomyocytes from efficiently generated human iPSCs and a novel method of measuring contractility | |
| JP2016523254A5 (enExample) | ||
| Lewallen et al. | Osteogenic potential of human adipose-tissue-derived mesenchymal stromal cells cultured on 3D-printed porous structured titanium | |
| Shams et al. | The utility of dermal fibroblasts in treatment of skin disorders: a paradigm of recessive dystrophic epidermolysis bullosa | |
| Evangelatov et al. | The evolution of three-dimensional cell cultures towards unimpeded regenerative medicine and tissue engineering | |
| Savkovic et al. | Polycaprolactone fiber meshes provide a 3 D environment suitable for cultivation and differentiation of melanocytes from the outer root sheath of hair follicle | |
| Deepa et al. | Differential healing of full thickness rabbit skin wound by fibroblast loaded chitosan sponge | |
| JP2015231365A5 (enExample) | ||
| Hansen et al. | A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem/progenitor cells | |
| Cheng et al. | Differentiation of multipotent adult germline stem cells derived from mouse testis into functional endothelial cells |